Despite mutations in Rho GTPase-encoding genes representing uncommon events, it was described that RAC1-activating mutations are present in approximately 4–9% of melanomas (Krauthammer et al., 2012; Araiza-Olivera et al., 2018; del Maldonado and Dharmawardhane, 2018). The gene discussed is RAC1; the disease is melanoma.